Cascadia Capital, an investment bank serving middle market clients globally, is pleased to announce that its client Plant Response Inc., an industry consolidator of leading biologics-based solutions, recovered waste fertilizers and other crop input technologies, has been acquired by The Mosaic Company (NYSE: MOS), a global manufacturer of agricultural fertilizers and chemicals.
Plant Response brings together a diverse portfolio of biologics-based crop inputs having recently acquired the following entities: Koch Biological Solutions (2019), Pathway BioLogic (2020), and WISErg (2021). With 16 commercialized products, Plant Response aims to enhance grower returns by improving nutrient use and efficiency, disease defense, biocontrol, and tolerance to abiotic stress, and increase overall crop yields.
Plant Response was backed by leading food and agriculture investors and strategics, including Alexandria Venture Investments, Koch Agronomic Holdings, Laird Norton Company, iSelect Fund, Second Avenue Partners, Middleland Capital, Yara, Novozymes, and Leaps by Bayer, among others.
“It was a true pleasure working with the Plant Response team. We are excited to see what they are able to accomplish in partnership with The Mosaic Company,” noted Scott Porter, Cascadia Capital Managing Director. “We continue to see increased demand for biologic-based crop solutions and believe acquisitions in this space will accelerate in the near-term as large strategics seek to augment their conventional crop offerings.”
Cascadia is a leading investment bank for companies in the AgTech sector. Recent transactions include the Series D equity investment in AgBiome led by Blue Horizon and Novalis Life Sciences, the acquisition of Conservis Corporation by TELUS Agriculture and Rabobank, and the acquisition of Cytozyme Laboratories by Verdesian Life Sciences.
For more information about this transaction, please contact:
Or other senior members of the Food, Beverage & Agribusiness team at Cascadia Capital:
Chairman & CEO